Company profile for Kestrel Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Kestrel Therapeutics is a clinical-stage biotechnology company focused on developing next-generation small-molecule therapies targeting KRAS-driven cancers. Using advanced scientific approaches, the company designs potent and selective inhibitors that act on both active and inactive KRAS states. Its lead candidate, KST-6051, is progressing toward clinical evaluation for multiple solid tumors. Based in the United States, Kestre...
Kestrel Therapeutics is a clinical-stage biotechnology company focused on developing next-generation small-molecule therapies targeting KRAS-driven cancers. Using advanced scientific approaches, the company designs potent and selective inhibitors that act on both active and inactive KRAS states. Its lead candidate, KST-6051, is progressing toward clinical evaluation for multiple solid tumors. Based in the United States, Kestrel is committed to delivering transformative oncology treatments for patients with high unmet medical needs.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
321 Arsenal Street, Suite 301 Watertown, MA 02472
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

IPhEB Russia

Not Confirmed

envelop Contact Supplier

IPhEB Russia

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty